Skip to search boxSkip to navigationSkip to main content

Obesity and ADHD: Exploring the role of body composition, BMI polygenic risk score, and reward system genes

  • Thais Martins-Silva
    ,
  • Juliana dos Santos Vaz
    ,
  • Júlia Pasqualini Genro
    ,
  • Mara Helena Hutz
    ,
  • ,
  • Nina Roth Mota
  • Programa de Pós-Graduação em Epidemiologia da Universidade Federal de Pelotas (UFPel)
    ,
  • Universidade Federal de Ciências da Saúde de Porto Alegre
    ,
  • Federal University of Rio Grande do Sul
    ,
  • ,
  • ,
  • Universidade Federal do Rio Grande
Research Output:
Contribution to journal
Article
Peer-review

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 529-536 (8 pages)

Journal (Volume, Issue Number)

Journal of Psychiatric Research (Volume 136)

Publication milestones

  • Published - 04/2021

Publication status

Published - 04/2021

ISSN

0022-3956

Publication IDs

  • Scopus: 85094600989
  • PubMed: 33127071

Abstract

The association between obesity and attention-deficit hyperactivity disorder (ADHD) has been extensively reported in the literature. However, the potential mechanisms underlying this association are not completely understood. This study aimed to evaluate the association between body composition and ADHD and explore the possible genetic mechanisms involved. We used data from the 1982 Pelotas (Brazil) Birth Cohort at age 30-year follow-up (N = 3630). We first used logistic regression analysis to test whether body mass index (BMI), fat mass (FM), and fat-free mass (FFM) were associated with ADHD. We further tested the association between BMI polygenic risk score (BMI-PRS) and ADHD and the role of the genes upregulated in the reward system using a gene-set association approach. BMI (odds ratio [OR] = 1.05; 95% confidence interval [CI], 1.00–1.09; p = 0.038) and FM (OR = 1.04; 95% CI, 1.00–1.07; p = 0.043) were associated with ADHD. The BMI-PRS was associated with ADHD (using p-value threshold (PT) = 0.4; OR = 1.65; 95% CI, 1.02–2.65) at a nominal level. In gene-set analysis, the reward system genes were associated with BMI in subjects with a high BMI-PRS score, considering PT = 0.4 (p = 0.014). The results suggest that BMI genetic components, especially those genes related to the reward system, may be involved in this association.

Funding Details

This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) – Finance Code 001 . Dr. Nina Roth Mota supported by the European Community's Horizon 2020 Programme ( H2020/2014–2020 ) under grant agreements n° 667302 (CoCA). LAR has been a member of the speakers bureau/advisory board and/or acted as a consultant for Eli-Lilly, Janssen-Cilag, Medice, Novartis and Shire in the last 3 years. He receives authorship royalties from Oxford Press and Artmed. He has also received travel awards from Shire for his participation in the 2018 APA meetings and from Novartis to take part of the 2016 AACAP meeting. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the last 3 years: Janssen – Cilag, Novartis, and Shire. The remaining authors declare that they have no conflict of interest. This study was financed in part by the Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior - Brasil (CAPES) ? Finance Code 001. Dr. Nina Roth Mota supported by the European Community's Horizon 2020 Programme (H2020/2014?2020) under grant agreements n? 667302 (CoCA). LAR has been a member of the speakers bureau/advisory board and/or acted as a consultant for Eli-Lilly, Janssen-Cilag, Medice, Novartis and Shire in the last 3 years. He receives authorship royalties from Oxford Press and Artmed. He has also received travel awards from Shire for his participation in the 2018 APA meetings and from Novartis to take part of the 2016 AACAP meeting. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the last 3 years: Janssen ? Cilag, Novartis, and Shire. The remaining authors declare that they have no conflict of interest.
FundersFunding numbers
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
-
European Community's Horizon 2020 Programme
-
Juvenile Bipolar Disorder
-
Novartis
-
H2020
667302
COCA
-
Cilag
-
CAPES
-
Shire
-

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Citations
16
Captures
62
Social media
42

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well